BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36043756)

  • 1. Phosphoserine Aminotransferase 1: A Metabolic Enzyme Target of Cancers.
    Yang X; Li C; Chen Y
    Curr Cancer Drug Targets; 2023; 23(3):171-186. PubMed ID: 36043756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer.
    Metcalf S; Dougherty S; Kruer T; Hasan N; Biyik-Sit R; Reynolds L; Clem BF
    Clin Exp Metastasis; 2020 Feb; 37(1):187-197. PubMed ID: 31630284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear Pyruvate Kinase M2 (PKM2) Contributes to Phosphoserine Aminotransferase 1 (PSAT1)-Mediated Cell Migration in EGFR-Activated Lung Cancer Cells.
    Biyik-Sit R; Kruer T; Dougherty S; Bradley JA; Wilkey DW; Merchant ML; Trent JO; Clem BF
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Phosphoserine Aminotransferase 1 (PSAT1) Predicts Poor Prognosis and Associates with Tumor Progression in Human Esophageal Squamous Cell Carcinoma.
    Liu B; Jia Y; Cao Y; Wu S; Jiang H; Sun X; Ma J; Yin X; Mao A; Shang M
    Cell Physiol Biochem; 2016; 39(1):395-406. PubMed ID: 27372650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells.
    Yang Y; Wu J; Cai J; He Z; Yuan J; Zhu X; Li Y; Li M; Guan H
    Int J Cancer; 2015 Feb; 136(4):E39-50. PubMed ID: 25142862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
    Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNγ axis.
    Chan YC; Chang YC; Chuang HH; Yang YC; Lin YF; Huang MS; Hsiao M; Yang CJ; Hua KT
    Oncogene; 2020 Mar; 39(12):2509-2522. PubMed ID: 31988456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions.
    Jin HO; Hong SE; Kim JY; Jang SK; Kim YS; Sim JH; Oh AC; Kim H; Hong YJ; Lee JK; Park IC
    Anticancer Res; 2019 Dec; 39(12):6723-6730. PubMed ID: 31810937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma.
    Luo MY; Zhou Y; Gu WM; Wang C; Shen NX; Dong JK; Lei HM; Tang YB; Liang Q; Zou JH; Xu L; Ma P; Zhuang G; Bi L; Xu L; Zhu L; Chen HZ; Shen Y
    Cancer Res; 2022 Oct; 82(19):3516-3531. PubMed ID: 36193649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1.
    Yan S; Jiang H; Fang S; Yin F; Wang Z; Jia Y; Sun X; Wu S; Jiang T; Mao A
    Cell Physiol Biochem; 2015; 37(1):375-86. PubMed ID: 26316084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells.
    Vié N; Copois V; Bascoul-Mollevi C; Denis V; Bec N; Robert B; Fraslon C; Conseiller E; Molina F; Larroque C; Martineau P; Del Rio M; Gongora C
    Mol Cancer; 2008 Jan; 7():14. PubMed ID: 18221502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of Notch1 and β-catenin in response to ER- breast cancer-specific up-regulation of PSAT1 mediates distant metastasis.
    Zhu S; Wang X; Liu L; Ren G
    Transl Oncol; 2022 Jun; 20():101399. PubMed ID: 35339029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of the effects of microRNA-145-5p and phosphoserine aminotransferase 1 in colon cancer.
    Ding R; Hong W; Huang L; Shao J; Yu W; Xu X
    Bioengineered; 2022 May; 13(5):12794-12806. PubMed ID: 35615948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-365 suppresses cell growth and invasion in esophageal squamous cell carcinoma by modulating phosphoserine aminotransferase 1.
    Sun C; Zhang X; Chen Y; Jia Q; Yang J; Shu Y
    Cancer Manag Res; 2018; 10():4581-4590. PubMed ID: 30410394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSAT1 Regulated Oxidation-Reduction Balance Affects the Growth and Prognosis of Epithelial Ovarian Cancer.
    Zhang Y; Li J; Dong X; Meng D; Zhi X; Yuan L; Yao L
    Onco Targets Ther; 2020; 13():5443-5453. PubMed ID: 32606761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis.
    Liao KM; Chao TB; Tian YF; Lin CY; Lee SW; Chuang HY; Chan TC; Chen TJ; Hsing CH; Sheu MJ; Li CF
    J Cancer; 2016; 7(9):1088-94. PubMed ID: 27326252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast cancer cells.
    Wang H; Fang Q; You S; Wu Y; Zhang C
    Genes Genomics; 2023 Jan; 45(1):39-47. PubMed ID: 36371491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Phosphoserine Aminotransferase 1 Regulates Insulin Sensitivity in Mice via Tribbles Homolog 3.
    Yu J; Xiao F; Guo Y; Deng J; Liu B; Zhang Q; Li K; Wang C; Chen S; Guo F
    Diabetes; 2015 May; 64(5):1591-602. PubMed ID: 25503742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer.
    Gao S; Ge A; Xu S; You Z; Ning S; Zhao Y; Pang D
    J Exp Clin Cancer Res; 2017 Dec; 36(1):179. PubMed ID: 29216929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous and Endogenous Sources of Serine Contribute to Colon Cancer Metabolism, Growth, and Resistance to 5-Fluorouracil.
    Montrose DC; Saha S; Foronda M; McNally EM; Chen J; Zhou XK; Ha T; Krumsiek J; Buyukozkan M; Verma A; Elemento O; Yantiss RK; Chen Q; Gross SS; Galluzzi L; Dow LE; Dannenberg AJ
    Cancer Res; 2021 May; 81(9):2275-2288. PubMed ID: 33526512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.